Novavax had 16 analyst reports since August 11, 2015 according to SRatingsIntel. A total number of 6 analysts provided estimations over revenues. The firm is expected to announce its next earnings results after the market closes on …
Novavax, Inc. (NASDAQ: NVAX) is having an incredibly strong day in the pre-market hours today, and for good reason. The company released earnings for he second …
The stock attained the volume of 8509590 shares contrast to its average daily volume of 7.65M shares. Novavax Inc (NASDAQ:NVAX) shares traded 1.94% up during most recent session to reach at the closing price of $0.99. State …
Novavax Inc now has $288.30 million valuation. Out of the analyst recommendations 1 rate Novavax Inc (NASDAQ:NVAX) stock a Buy, 1 rate the stock Outperform, 5 rate Hold, 0 rate Underperform and 0 recommend a Sell. 8,512,895 shares …
(NASDAQ:NVAX). Tower Rech Capital Ltd Liability Company (Trc) invested in 500 shares or 0% of the stock. Finally, Teachers Advisors LLC boosted its stake in Novavax by 4.2% in the fourth quarter. Finally, Goldman Sachs Group Inc. …
Novavax, Inc. (NVAX) will report its next earnings on Aug 08 AMC ... Inc. and for the current quarter 7 analysts have projected that the stock could give an Average …
Cantor Fitzgerald now has a $2.00 price target on the biopharmaceutical company's stock. Creative Planning owned about 0.17% of Novavax worth $543,000 at the end of the most recent reporting period. Novavax Inc (NASDAQ:NVAX) as of …
NVAX RSV vaccine targets the fusion protein (F-protein ... I have no business relationship with any company whose stock is mentioned in this article. Editor's …
NVAX has been the topic of a number of research reports. During its last trading session, Stock traded with the total exchanged volume of 0.64 million shares. The company now has a Return on Equity of -787.4% and a Return on …